We are live on ! Find out more
CCXI

ChemoCentryx, Inc.

Delisted

CCXI was delisted on the 19th of October, 2022.

71 hedge funds and large institutions have $61.3M invested in ChemoCentryx, Inc. in 2016 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 29 increasing their positions, 13 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

123% more repeat investments, than reductions

Existing positions increased: 29 | Existing positions reduced: 13

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

9% less first-time investments, than exits

New positions opened: 10 | Existing positions closed: 11

1% less funds holding

Funds holding: 7271 (-1)

70% less capital invested

Capital invested by funds: $203M → $61.3M (-$142M)

90% less call options, than puts

Call options by funds: $15K | Put options by funds: $155K

Holders
71
Holders Change
-1
Holders Change %
-1.39%
% of All Funds
1.89%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
10
Increased
29
Reduced
13
Closed
11
Calls
$15K
Puts
$155K
Net Calls
-$140K
Net Calls Change
+$182K
Name Holding Trade Value Shares
Change
Change in
Stake
Manulife (Manufacturers Life Insurance)
51
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$49K +$8.38K +2,302 +12%
NFA
52
Nationwide Fund Advisors
Ohio
$47K
Creative Planning
53
Creative Planning
Kansas
$45K -$7.28K -2,000 -10%
Nomura Holdings
54
Nomura Holdings
Japan
$42K +$61.9K +17,000 New
AIG
55
American International Group
New York
$41K
Wells Fargo
56
Wells Fargo
California
$40K +$2.66K +730 +5%
Two Sigma Advisers
57
Two Sigma Advisers
New York
$38K +$56.2K +15,441 New
VOYA Investment Management
58
VOYA Investment Management
Georgia
$32K
PPA
59
Parametric Portfolio Associates
Washington
$29K +$2.91K +798 +7%
RG
60
Redmile Group
California
$25K -$194K -53,189 -84%
FIM
61
Fernwood Investment Management
Massachusetts
$25K
Morgan Stanley
62
Morgan Stanley
New York
$22K -$21K -5,771 -40%
BJ
63
BlackRock Japan
Japan
$15K +$14K +3,834 +178%
Bank of Montreal
64
Bank of Montreal
Ontario, Canada
$10K +$9.48K +2,604 +179%
GWM
65
Geneos Wealth Management
Colorado
$10K +$14.6K +4,000 New
BlackRock
66
BlackRock
New York
$5K +$1.48K +406 +25%
CG
67
Cutler Group
California
$3K -$26.6K -7,291 -85%
Northwestern Mutual Wealth Management
68
Northwestern Mutual Wealth Management
Wisconsin
$1K +$1.52K +417 New
Geode Capital Management
69
Geode Capital Management
Massachusetts
$381 -$4.66K -1,279 -0.8%
Westfield Capital Management
70
Westfield Capital Management
Massachusetts
-$8.93M -1,102,332 Closed
EAM
71
EverPoint Asset Management
Connecticut
-$3.85M -475,000 Closed
MLICM
72
Metropolitan Life Insurance Company (MetLife)
New York
-$184K -22,688 Closed
Point72 Asset Management
73
Point72 Asset Management
Connecticut
-$157K -19,400 Closed
PNC Financial Services Group
74
PNC Financial Services Group
Pennsylvania
-$40.2K -11,034 -98%
Group One Trading
75
Group One Trading
Illinois
-$45K -5,500 Closed

CCXI Hedge Fund Activity: Q1 2016 in Review

71 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in ChemoCentryx, Inc. (CCXI) for Q1 2016, worth a combined $61.3M — down 70% from $203M a quarter earlier.

Sellers outnumbered buyers: 11 funds closed out of CCXI and 10 opened new positions — a net loss of 1 holder — while 13 trimmed existing stakes and 29 added.

The largest buyer was BVF Inc, adding an estimated $5.48M. The largest seller was Westfield Capital Management, exiting entirely with an estimated $8.93M sold.

  • 71 institutional investors held ChemoCentryx, Inc. (CCXI) as of Q1 2016, down from 72 in Q4 2015.
  • Funds reported $61.3M of ChemoCentryx, Inc. stock for Q1 2016, down 70% quarter-over-quarter.
  • 10 funds opened new ChemoCentryx, Inc. positions in Q1 2016 and 11 closed out, a net change of -1 holder.
  • The largest ChemoCentryx, Inc. buyer in Q1 2016 was BVF Inc, an estimated $5.48M added.
  • The largest ChemoCentryx, Inc. seller in Q1 2016 was Westfield Capital Management, an estimated $8.93M sold.

Based on aggregated 13F filings for Q1 2016.